Single-cell profiling-guided combination therapy of c-Fos and histone deacetylase inhibitors in diffuse large B-cell lymphoma.
Luqiao WangZijuan WuYi XiaXueying LuJi LiLei FanChun QiaoHairong QiuDanling GuWei XuJianyong LiHui JinPublished in: Clinical and translational medicine (2022)
Altogether, we found an HDACi, LAQ824, with high efficacy in DLBCL and provided a promising HDACi-based combination therapy strategy.